切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (06) : 580 -585. doi: 10.3877/cma.j.issn.2095-3232.2022.06.010

临床研究

ICG荧光显像技术在肝癌腹腔镜肝切除术中应用的安全性及疗效
胡宇1, 马金良1, 葛勇胜1, 余继海1, 张传海1, 刘文斌1, 荚卫东1,()   
  1. 1. 230001 合肥,中国科学技术大学附属第一医院肝脏外科
  • 收稿日期:2022-09-02 出版日期:2022-12-10
  • 通信作者: 荚卫东
  • 基金资助:
    安徽省重点研究和开发计划项目(201904a07020096)

Safety and efficacy of ICG fluorescence imaging in laparoscopic hepatectomy for primary liver cancer

Yu Hu1, Jinliang Ma1, Yongsheng Ge1, Jihai Yu1, Chuanhai Zhang1, Wenbin Liu1, Weidong Jia1,()   

  1. 1. Department of Hepatic Surgery, the First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, China
  • Received:2022-09-02 Published:2022-12-10
  • Corresponding author: Weidong Jia
引用本文:

胡宇, 马金良, 葛勇胜, 余继海, 张传海, 刘文斌, 荚卫东. ICG荧光显像技术在肝癌腹腔镜肝切除术中应用的安全性及疗效[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 580-585.

Yu Hu, Jinliang Ma, Yongsheng Ge, Jihai Yu, Chuanhai Zhang, Wenbin Liu, Weidong Jia. Safety and efficacy of ICG fluorescence imaging in laparoscopic hepatectomy for primary liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(06): 580-585.

目的

探讨ICG荧光显像技术在原发性肝癌(肝癌)腹腔镜肝切除术(LH)中应用的安全性及疗效。

方法

回顾性分析2018年1月至2021年12月在中国科学技术大学附属第一医院行LH的121例肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男98例,女23例;年龄19~85岁,中位年龄56岁。根据手术方式不同将患者分为ICG荧光显像腹腔镜肝切除术(FGLH)组(52例)和LH组(69例)。比较两组围手术期情况及生存情况。两组手术时间比较采用t检验,第一肝门阻断时间、术中出血量比较采用秩和检验,术后并发症发生率比较采用χ2检验。生存分析采用Kaplan-Meier法和Log-rank检验。

结果

FGLH组平均手术时间为(238±72)min,明显低于LH组的(291±117)min(t=-2.868,P<0.05)。FGLH组第一肝门阻断时间、术中出血量中位数分别为22(30)min、200(200)ml,明显少于FH组的25(25)min、200(300)ml(Z=-1.997,-2.067;P<0.05)。FGLH组术后并发症发生率为10%(5/52),明显低于LH组的25%(17/69) (χ2=4.498,P<0.05)。两组术后均未发生严重并发症,均无围手术期死亡。FGLH组和LH组中位生存期分别为50.3、39.4个月,两组累积生存率比较差异无统计学意义(χ2=3.196,P>0.05)。

结论

ICG荧光显像技术在LH中应用安全、有效,具有手术时间短、术中出血量少、术后并发症发生率低的优势。

Objective

To evaluate the safety and efficacy of indocyanine green (ICG) fluorescence imaging in laparoscopic hepatectomy (LH) for primary liver cancer (PLC).

Methods

Clinical data of 121 patients with PLC who underwent LH in the First Affiliated Hospital of University of Science and Technology of China from January 2018 to December 2021 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 98 patients were male and 23 female, aged from 19 to 85 years, with a median age of 56 years. According to different surgical approaches, all patients were divided into the ICG fluorescence imaging LH (FGLH) group (n=52) and LH group (n=69). Perioperative conditions and survival were compared betweentwo groups. The operation time between two groups was compared by t test. The occlusion time of porta hepatis and intraoperative blood loss were analyzed by rank-sum test. The incidence of postoperative complications was assessed by Chi-square test. Survival analysis was conducted by Kaplan-Meier method and Log-rank test.

Results

The average operation time in the FGLH group was (238±72) min, significantly shorter than (291±117) min in the LH group (t=-2.868, P<0.05). In the FGLH group, the median occlusion time of porta hepatis and intraoperative blood loss were 22(30) min and 200(200) ml, significantly less than 25(25) min and 200(300) ml in the FH group (Z=-1.997, -2.067; P<0.05). The incidence of postoperative complications in the FGLH group was 10%(5/52), significantly lower than 25%(17/69) in the LH group (χ2=4.498, P<0.05). No severe postoperative complications or perioperative death occurred in two groups. The median survival time in the FGLH and LH groups was 50.3 and 39.4 months. No significant difference was noted in the cumulative survival rate between two groups (χ2=3.196, P>0.05).

Conclusions

It is safe and effective to adopt ICG fluorescence imaging in LH, which requires short operation time, yields slight intraoperative blood loss and low incidence of postoperative complications.

图1 腹腔镜肝癌肝切除术中目标肝段ICG染色方法注:a为S6段术中正向染色法;b为S4段术中反向染色法;c为术前注射ICG显示肿瘤位置
表1 FGLH组和LH组肝癌患者一般资料比较
表2 FGLH组和LH组肝癌患者围手术期情况比较
图2 FGLH组和LH组肝癌患者术后Kaplan-Meier生存曲线注:FGLH为ICG荧光显像腹腔镜肝切除术,LH为腹腔镜肝切除术
[1]
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces,1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158.
[2]
中国研究型医院学会肝胆胰外科专业委员会. 腹腔镜肝切除术治疗肝细胞癌中国专家共识(2020版)[J]. 中华消化外科杂志, 2020, 19(11):1119-1134.
[3]
Ishizawa T, Kokudo N. The beginning of a new era of digestive surgery guided by fluorescence imaging[J]. Liver Cancer2014, 3(1):6-8.
[4]
中国研究型医院学会微创外科学专业委员会, 《腹腔镜外科杂志》编辑部. 吲哚菁绿荧光染色在腹腔镜肝切除术中应用的专家共识[J]. 腹腔镜外科杂志, 2019, 24(5):388-394.
[5]
Takamoto T. Improvement and development in anatomical hepatectomy for hepatocellular carcinoma[J]. Hepatobiliary Surg Nutr, 2021, 10(4):545-547.
[6]
Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identifification of liver cancers by using indocyanine green fluorescent imaging[J]. Cancer, 2009, 115(11):2491-2504.
[7]
Yokoyama N, Otani T, Hashidate H, et al. Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study[J]. Cancer, 2012, 118(11):2813-2819.
[8]
Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection[J]. World J Surg, 2008, 32(8):1763-1767.
[9]
Zhou Y, Lin Y, Jin HS, et al. Real-time navigation guidance using fusion indocyanine green fluorescence imaging in laparoscopic non-anatomical hepatectomy of hepatocellular carcinomas at segments 6, 7, or 8 (with videos)[J]. Med Sci Monit, 2019(25):1512-1517.
[10]
肖二卫, 陶连元, 魏艳奎, 等. 荧光腹腔镜在肝细胞癌根治性切除术中的应用[J]. 中华肝胆外科杂志, 2019, 25(2):87-89.
[11]
方驰华, 张鹏, 罗火灵, 等. 增强现实导航技术联合吲哚菁绿分子荧光影像在三维腹腔镜肝切除术中的应用[J]. 中华外科杂志, 2019, 57(8):578-584.
[12]
Lu H, Gu J, Qian XF, et al. Indocyanine green fluorescence navigation in laparoscopic hepatectomy: a retrospective single-center study of 120 cases[J]. Surg Today, 2020, 51(5):695-702.
[13]
隋明昊, 王宏光, 陈明易, 等. 吲哚菁绿荧光融合影像技术在解剖性肝切除手术中的应用[J]. 中华肝胆外科杂志201723(11):754-757.
[14]
Yokoyama N, Otani T, Hashidate H, et al. Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study[J]. Cancer, 2012, 118(11):2813-2819.
[15]
蔡秀军, 蔡柳新. 腹腔镜肝切除术关键技术、难点及对策[J]. 中国实用外科杂志, 2017, 37(5):461-465.
[16]
曾思略, 曾宁, 祝文, 等. 三维可视化联合吲哚菁绿荧光影像技术在原发性肝癌诊治中的价值[J]. 南方医科大学学报, 2019, 39(12):1402-1408.
[17]
Yamamoto Y, Ikai I, Kume M, et al. New simple technique for hepatic parenchymal resection using a cavitron ultrasonic surgical aspirator and bipolar cautery equipped with a channel for water dripping[J]. World J Surg, 1999, 23(10):1032-1037.
[18]
Zhang YM, Shi R, Hou JC, et al. Liver tumor boundaries identified intraoperatively using real-time indocyanine green fluorescence imaging[J]. J Cancer Res Clin Oncol, 2017, 143(1):51-58.
[19]
Huang JW, Su WL, Wang SN. Alternative laparoscopic intracorporeal Pringle maneuver by Huang's loop[J]. World J Surg, 2018, 42(10):3312-3315.
[20]
张传海, 余继海, 马金良, 等. "改良黄氏方法"在腹腔镜肝切除第一肝门血流阻断中的应用[J]. 肝胆外科杂志, 2021, 29(5):345-349.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[3] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[8] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[9] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[10] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[11] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[12] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[13] 张继新, 胡军红, 谢爽, 武祖印, 张春旭. 经阴道单孔腹腔镜阑尾切除术可行性及近期疗效分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 460-465.
[14] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[15] 邰清亮, 施波, 侍新宇, 陈国梁, 陈俊杰, 武冠廷, 王索, 孙金兵, 顾闻, 叶建新, 何宋兵. 腹腔镜次全结肠切除术治疗顽固性慢传输型便秘的疗效分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 478-483.
阅读次数
全文


摘要